Rare diseases
Investigational molecules
Locations
Back to Germany141 clinical trials in Herne, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Phase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
GermanyAdjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma
GermanyDurvalumab plus drug combination as total neoadjuvant therapy for patients with resectable gastroesophageal adenocarcinoma
GermanySafety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study
GermanyStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
GermanyEfficacy and safety of sarilumab plus prednisone versus prednisone alone in adults with early polymyalgia rheumatica
GermanyLong‑Term Safety and Efficacy of RO7790121 in Adults with Moderate to Severe Rheumatoid Arthritis: Extension Study
GermanyTulisokibart for Psoriatic Arthritis in Adults
GermanyA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
GermanyStudy of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy
GermanyStudy of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation
GermanyStudy of zanidatamab with drug combination for patients with HER2 and PD-L1 positive advanced gastroesophageal cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, bladder cancer, and prostate cancer treatments. Studies evaluate novel therapeutic combinations and targeted approaches for improved patient outcomes.
Multiple studies are exploring combination therapies and comparing treatment efficacy in various cancer stages.
Comprehensive research into psoriatic arthritis, rheumatoid arthritis, and axial spondyloarthritis. Trials evaluate new biological treatments and therapeutic approaches.
Focus on improving treatment outcomes for patients with various rheumatic conditions.
Advanced studies in chronic lymphocytic leukemia and acute myeloid leukemia. Investigations of innovative treatment combinations and targeted therapies.
Clinical trials aim to improve survival rates and treatment effectiveness in blood cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
